What Happened to Alexander Zverev?
Alexander Zverev, a German professional tennis player, was diagnosed with Type 1 diabetes at age four but kept his condition private for years. In August 2022, he publicly disclosed his diagnosis and launched the Alexander Zverev Foundation to support children with diabetes. He has since become a Grand Slam champion, winning the French Open in 2026, while openly managing his diabetes on court.
Quick Answer
Alexander Zverev has Type 1 diabetes, diagnosed at age four. He publicly revealed his condition in August 2022, simultaneously launching a foundation to aid children with diabetes. Despite initial fears that it would hinder his career, Zverev actively manages his diabetes on court with insulin pens and continuous glucose monitors, demonstrating that the condition does not limit elite athletic performance. As of 2026, he is a French Open champion and continues to compete at the highest level, advocating for diabetes awareness.
📊Key Facts
📅Complete Timeline14 events
Diagnosed with Type 1 Diabetes
Alexander Zverev was diagnosed with Type 1 diabetes at the age of four, a condition he would keep private for many years due to fears of judgment and career limitations.
Wins First ATP Finals Title
Zverev secured his first ATP Finals title, a significant achievement in his career while managing his diabetes privately.
Reaches US Open Final
Zverev made his first Grand Slam final appearance at the US Open, showcasing his ability to compete at the highest level despite his hidden condition.
Wins Olympic Gold and Second ATP Finals
He achieved Olympic gold at the Tokyo Games and won his second ATP Finals title, further establishing himself among the tennis elite.
Publicly Discloses Diabetes and Launches Foundation
Zverev announced his Type 1 diabetes diagnosis to the public and simultaneously launched the Alexander Zverev Foundation, dedicated to supporting children with the condition.
French Open Insulin Incident
During the French Open, Zverev was initially questioned by officials for injecting insulin on court, leading to widespread criticism and a subsequent clarification of rules for athletes with diabetes.
Partners with Medtronic Diabetes
Zverev announced a global advocacy partnership with Medtronic Diabetes (MiniMed) to raise awareness for Type 1 diabetes and inspire others.
Reaches Australian Open Final
He reached his second Grand Slam final at the Australian Open, continuing his strong performance in major tournaments.
Health Scare at Cincinnati Open
Zverev experienced dizziness and breathing issues during a quarter-final match at the Cincinnati Open, highlighting the ongoing physical demands and health management required.
Wins Maiden Grand Slam at French Open
Alexander Zverev won his first Grand Slam title at the French Open, making history as the first known male tennis player with Type 1 diabetes to achieve this feat.
Glucose Sensor Malfunction in Halle
During a Wimbledon warm-up event in Halle, Zverev's glucose sensor provided an incorrect reading, leading to an accidental overdose of insulin and a difficult match.
Reaches Wimbledon Final
Following his French Open victory, Zverev continued his strong Grand Slam season by reaching the Wimbledon final.
Achieves World No. 2 Ranking
Zverev reached and maintained a career-high ATP ranking of World No. 2, reflecting his consistent performance throughout the 2026 season.
Reaches US Open Final
Zverev reached the final of the US Open, marking his third Grand Slam final appearance in 2026.
Follow this story
Get an email when this timeline gets a major update.
🔍Deep Dive Analysis
Alexander 'Sascha' Zverev, one of the world's top tennis players, has lived with Type 1 diabetes since he was four years old. For much of his early career, Zverev chose to keep his diagnosis private, fearing that it might be perceived as a weakness by opponents or that it would limit his professional aspirations. He recalled being told as a child that competing at the highest level with diabetes would be impossible, a notion he and his family refused to accept.
A significant turning point came on August 6, 2022, when Zverev publicly announced his Type 1 diabetes diagnosis. This disclosure coincided with the launch of the Alexander Zverev Foundation, based in his hometown of Hamburg. The foundation's mission is to support children with Type 1 diabetes, providing essential insulin and medication, particularly in developing countries, and promoting healthy, active lifestyles. His decision to go public was driven by a desire to inspire others and show that living with diabetes does not mean sacrificing one's dreams.
Managing Type 1 diabetes as an elite athlete presents unique challenges. Zverev constantly monitors his blood glucose levels using a continuous glucose monitor (CGM) and administers insulin with a pen during changeovers on court when necessary. This on-court management gained significant attention during the 2023 French Open when tournament officials initially questioned his insulin injection, deeming it 'weird.' This incident sparked an international outcry from diabetes organizations and advocates, who emphasized that insulin is a life-saving medication, not a performance-enhancing drug. The French Open subsequently reversed its stance, allowing Zverev to manage his condition openly.
Zverev's journey has been marked by both triumphs and challenges related to his health. In 2025, he partnered with Medtronic Diabetes (MiniMed) to further raise global awareness and challenge misconceptions about Type 1 diabetes. In August 2025, he experienced a health scare during the Cincinnati Open, reporting dizziness and breathing issues, though he recovered to continue playing. A more direct diabetes-related challenge occurred in June 2026 at a Wimbledon warm-up event in Halle, Germany, where a faulty glucose sensor led him to accidentally inject too much insulin, causing him to feel 'awful' and lose the match.
Despite these hurdles, Zverev has achieved remarkable success. In June 2026, he won his first Grand Slam title at the French Open, becoming the first known male tennis player with Type 1 diabetes to do so. He followed this by reaching the Wimbledon final in July 2026 and the US Open final in September 2026, solidifying his position as a top contender. As of September 13, 2026, Zverev is ranked World No. 2. His career demonstrates that with diligent management and support, Type 1 diabetes does not have to be a barrier to achieving the highest levels of professional sport.
What If...?
Explore alternate histories. What if Alexander Zverev made different choices?